idiopathic pulmonary arterial hypertension
idiopathic pulmonary arterial hypertension
Explore linked clinical trials. Standard reference: MONDO:00019998 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hormonal, Metabolic, and Signaling Interactions in PAH | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Not stated | 2026-09-25 | NCT01884051 | |
| Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH) | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Not stated | 2026-05-29 | NCT05462574 | |
| Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Recruiting | Not applicable | 2026-05-22 | NCT07604805 | |
| Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled Trial | Familial Primary Pulmonary Hypertension, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary hypertension, respiratory system disorder | Enrolling by invitation | Not applicable | 2026-04-30 | NCT07558460 | |
| Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals | Familial Primary Pulmonary Hypertension, cardiovascular disorder, hypertensive disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-03-10 | NCT05584722 | |
| 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, connective tissue disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 2 | 2026-02-24 | NCT06104228 | |
| Pulmonary Hypertension Biorepository and Registry | Familial Primary Pulmonary Hypertension, Hypoxia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, chronic thromboembolic pulmonary hypertension, congenital generalized lipodystrophy type 3, hypertensive disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, pulmonary hypertension, primary, 2, pulmonary hypertension, primary, 3, pulmonary hypertension, primary, 4, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2025-08-01 | NCT04808596 | |
| Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, connective tissue disorder, idiopathic pulmonary arterial hypertension, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2025-01-29 | NCT03992755 |